CASE REPORT article
Front. Oncol.
Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1593049
Combination of platinum-based chemotherapy and bemarituzumab in a young adult patient with NBN-mutated, FGFR2b-positive, and microsatellite stable (MSS) unresectable advanced gastric cancer: a rare clinical case report and literature review
Provisionally accepted
- Lanzhou University Second Hospital, Lanzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
.
Keywords: gastric cancer, NbN, FGFR2b, Bemarituzumab, combination therapy
Received: 13 Mar 2025; Accepted: 23 Jun 2025.
Copyright: © 2025 Ma, Liu, Liao, Li, Ma, Qi, Maswikiti, Chen and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hao Chen, Lanzhou University Second Hospital, Lanzhou, China
Zhijian Han, Lanzhou University Second Hospital, Lanzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.